The patient leaflet regarding recommended dosing was inconsistent with the approved Summary of Product Characteristics, which could lead to incorrect use and overdose manifested by increased volume of bronchial secretions. Potential effects: overdose, worsening cough and adverse drug reactions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Use the medicine only in accordance with the updated leaflet and the recommendations of your doctor or pharmacist; if you have any doubts about dosing or leaflet content, consult a pharmacist or docto...
The Chief Pharmaceutical Inspector revoked the decision to withdraw from the market nationwide Flegafortan 1.6 mg/ml, syrup, batches 0129G and 0130G after leaflet correction and confirmation that repa...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related